Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349(9055):825-832.

Publication Type:

Journal Article

Authors:

Poynard, T.; Bedossa, P.; Opolon, P.

Source:

Lancet, Volume 349, Issue 9055, p.825-832 (1997)

Keywords:

Adult, Age Factors, Alcohol Drinking, Biopsy, complications, Cross-Sectional Studies, Disease Progression, epidemiology, Female, France, Genotype, hepatitis, Hepatitis C, Hepatitis,Chronic, Human, Infection, Liver, Liver Cirrhosis, Male, methods, Middle Age, pathology, Prevalence, Risk Factors, Sex Factors, Support,Non-U.S.Gov't, Time Factors, virology

Cited On:

HCV Testing and Linkage to Care

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/9121257

Export Citation:

RIS Format

Top